Tris Pharma, Inc. Goes on Hiring Binge; Aims to Increase Workforce by 40 Pct. in Next 6 Months

Tris Pharma, Inc. Goes on Hiring Binge; Aims to Increase Workforce by 40 Pct. in Next 6 Months

MONMOUTH JUNCTION, N.J., June 13, 2012 -- Tris Pharma, a technology driven specialty pharmaceutical company announced that it is hosting job fairs for the two consecutive Saturdays, June 16th and June 23rd to fill over 50 new positions in manufacturing and quality control departments at its central New Jersey facility.

 

With the new and pending approvals, Tris Pharma is preparing to launch several new products in the coming six months. Toward that goal, Tris is looking to hire 35 new packaging technicians in various shifts, over 10 manufacturing operators and another 15 quality control and assurance positions effective immediately.

"Our new technology deployment has paid rich dividends and as a result we are fortunate to be growing in today's economy," said Cheryl Patnick, Vice President of Human Resources. "In order to meet our production goals, we are looking for skilled Manufacturing and Quality professionals. While we are looking to hire experienced candidates, we offer training for qualified individuals who are motivated to excel and want to be a part of our team."

The job fair will allow potential hires to interact with the management and learn more about Tris Pharma and various opportunities it provides to new employees. Tris offers competitive salaries and full benefit packages to newly hired employees. Tris Pharma's job fairs will be held onSaturday, June 16 and Saturday, June 23, 2012 from 9:00 am 2:00 pm. Light refreshments will be served.Applicants are encouraged to visit Tris' website www.trispharma.com to learn more about the specific positions and shifts available.

About Tris Pharma
Tris Pharma is a specialty pharmaceutical company focused on the research and development of technologies driven products. Tris has pioneered the delivery of sustained release in the liquid, chewable/ODT and strip dosage forms so patients do not have to swallow a pill. Tris' Nobuse technology provides abuse deterrence for opioids and other abuse-prone drugs. Tris' R&D and manufacturing facilities are located inMonmouth Junction, New Jersey, USA. For more information, please visit www.trispharma.com.

SOURCE Tris Pharma
 

Suggested Articles

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

Boehringer Ingelheim is investing $50 million in an animal health plant in Puerto Rico, adding 105 jobs.

Teva will begin producing chemo drug vincristine in the U.S. but has resisted the idea that its withdrawal from the market led to a shortage.